ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,013,014 | -32.2% | 112,133 | -10.0% | 0.01% | -16.7% |
| Q2 2023 | $4,444,841 | +38.0% | 124,645 | -1.7% | 0.01% | +20.0% |
| Q1 2023 | $3,219,856 | -38.3% | 126,766 | -1.5% | 0.01% | -37.5% |
| Q4 2022 | $5,221,451 | +24.3% | 128,734 | +1.3% | 0.01% | +14.3% |
| Q3 2022 | $4,200,000 | -7.8% | 127,079 | -1.7% | 0.01% | 0.0% |
| Q2 2022 | $4,554,000 | -23.1% | 129,331 | +0.5% | 0.01% | -12.5% |
| Q1 2022 | $5,919,000 | -35.8% | 128,693 | -7.4% | 0.01% | -27.3% |
| Q4 2021 | $9,216,000 | +8.7% | 139,007 | +2.4% | 0.01% | 0.0% |
| Q3 2021 | $8,476,000 | -26.7% | 135,775 | -2.8% | 0.01% | -26.7% |
| Q2 2021 | $11,569,000 | +13.0% | 139,693 | -9.5% | 0.02% | +7.1% |
| Q1 2021 | $10,239,000 | -12.1% | 154,410 | +1.7% | 0.01% | -12.5% |
| Q4 2020 | $11,649,000 | +78.1% | 151,823 | -0.1% | 0.02% | +45.5% |
| Q3 2020 | $6,542,000 | +0.1% | 151,921 | +0.4% | 0.01% | -8.3% |
| Q2 2020 | $6,537,000 | +49.3% | 151,348 | -0.5% | 0.01% | +33.3% |
| Q1 2020 | $4,378,000 | -51.6% | 152,160 | +6.7% | 0.01% | -40.0% |
| Q4 2019 | $9,047,000 | +120.2% | 142,624 | -2.2% | 0.02% | +87.5% |
| Q3 2019 | $4,109,000 | +7.8% | 145,819 | +1.4% | 0.01% | 0.0% |
| Q2 2019 | $3,810,000 | +44.8% | 143,767 | +0.3% | 0.01% | +60.0% |
| Q1 2019 | $2,631,000 | +55.4% | 143,362 | +5.2% | 0.01% | +25.0% |
| Q4 2018 | $1,693,000 | -33.7% | 136,330 | +2.3% | 0.00% | -20.0% |
| Q3 2018 | $2,555,000 | +41.0% | 133,272 | +0.0% | 0.01% | +25.0% |
| Q2 2018 | $1,812,000 | +607.8% | 133,210 | -3.9% | 0.00% | +300.0% |
| Q1 2017 | $256,000 | +17.4% | 138,606 | -1.5% | 0.00% | – |
| Q4 2016 | $218,000 | -76.8% | 140,706 | +10.1% | 0.00% | -100.0% |
| Q3 2016 | $939,000 | +39.1% | 127,806 | +0.7% | 0.00% | +100.0% |
| Q2 2016 | $675,000 | – | 126,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |